Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mediccan Pharma is an Israeli medical cannabis company dedicated to the cultivation, manufacturing, and distribution of high-quality cannabis-based medicines. The company operates a state-of-the-art facility that adheres to strict GACP and IMC-GMP standards to ensure product consistency and safety for patients. Mediccan's product portfolio includes a variety of cannabis inflorescences and oils categorized by their THC and CBD concentrations. By focusing on pharmaceutical-grade production, the company aims to provide reliable therapeutic options for conditions such as chronic pain, neurological disorders, and palliative care. Mediccan is an active participant in the Israeli medical cannabis reform, supplying products to pharmacies and patients across the country.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mediccan Pharma.